SAMHSA, FDA Educate Public on Safe Use of Methadone

The Substance Abuse and Mental Health Services Administration (SAMHSA) and the U.S. Food and Drug Administration (FDA) recently launched an initiative to help ensure the safe use of methadone. Methadone is a prescription drug best known as a treatment for addiction and dependence on heroin and other narcotic pain medicines. It is also prescribed to treat moderate-to-severe chronic pain patients. The campaign responds to concerns about an escalating number of poisoning deaths linked to the improper use of this medication. The National Council on Patient Information and Education (NCPIE) is a named partner in the campaign.